New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
09:39 EDTCPIXCumberland, PT. SOHO Industri Pharmasi enter into exclusive licensing agreement
Cumberland Pharmaceuticals announced it has entered into an exclusive agreement with Indonesia's PT. SOHO Industri Pharmasi, a SOHO Group company, for the registration and commercialization of Caldolor, ibuprofen, Injection, which is used to treat pain and fever in the hospital setting. Under the terms of the agreement, SOHO receives an exclusive license to Caldolor for the Indonesian market. SOHO will be responsible for seeking regulatory approval, ongoing regulatory reporting, product marketing, distribution and sales in the territory following approval. Cumberland maintains responsibility for the intellectual property, product formulation, manufacturing and other supported activities. In exchange for the license to the product, Cumberland will receive upfront and milestone licensing payments, as well as transfer prices on future sales of the drug.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
16:08 EDTCPIXCumberland launches Caldolor in Australia
Subscribe for More Information
09:22 EDTCPIXCumberland announces approval of Caldolor injection
Cumberland announced the approval of Caldolor Injection for pediatric patients six months of age and older. The approval was based on data submitted to the U.S. Food and Drug Administration (FDA) as part of a post-marketing commitment following approval of Caldolor in adults in 2009. Caldolor is the first and only injectable non-steroidal anti-inflammatory drug approved for use in pediatric patients.
November 20, 2015
09:21 EDTCPIXCumberland announces favorable Acetadote patent ruling
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use